The role of intestinal bacteria in the causation and prevention of cancer: Modulation by diet and probiotics

Australian Journal of Dairy Technology

Volumn 54, Issue 2, 1999, Pages 103-121

  Parodi, Peter W ^a,b  

^a Dairy R and D Corporation   (Australia)

^b NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033464522     PISSN: 00049433     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (223)

1. Abdelali, H., Cassand, P., Soussotte, V., Daubeze, M., Bouley, C. and Narbonne, J.F. (1995), Effect of dairy products on initiation of precursor lesions of colon cancer in rats. Nutr. Cancer 24, 121-132.
2. Adachi, S. (1992), Lactic acid bacteria and the control of tumours, In The Lactic Acid Bacteria, Vol. 1. (Ed B.J.B. Wood) Elsevier Applied Science, London, pp 233-261.
3. Adlercreutz, H., Martin, F., Tikkanen, M.J. and Pulkkinen, M. (1975), Effect of ampicillin administration on the excretion of twelve oestrogens in pregnancy urine. Acta Endocr. 80, 551-557.
4. Adlercreutz, H., Hockerstedt, K., Bannwart, C., Bloigu, S., Hamalainen, E., Fotsis, T. and Ollus. A. (1987), Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J. Steroid Biochem. 27, 1135-1144.
5. Adlercreutz, H., Martin, F., Pulkkinen, M., Dencker, H., Rimer, U., Sjoberg, N-O. and Tikkanen, M.J. (1976), Intestinal metabolism of estrogens. J. Clin. Endocrinol. Metab. 43, 497-505.
6. Ames, B.N., Gold, L.S. and Willett, W.C. (1995), The causes and prevention of cancer. Proc. Natl Acad. Sci. USA 92, 5258-5265.
7. Ames, B.N., McCann, J. and Yamasaki, E. (1975), Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test. Mutat. Res. 31, 347-364.
8. Arimochi, H., Kinouchi, T., Kataoka, K., Kuwahara, T.and Ohnishi, Y. (1997), Effect of Intestinal bacteria on formation of azoxymethane-induced aberrant crypt foci in the rat colon. Biochem. Biophys. Res. Commun. 238, 753-757.
9. Asano, M., Karasawa, E. and Tayayama, T. (1986), Antitumour activity of Lactobacillus casei (LC 9018) against experimental mouse bladder tumour (MBT-2). J. Urol. 136, 719-721.
10. Aso, Y. and Akazan, H. (1992), Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial blabber cancer. Urol. Int. 49, 125-129.
11. Aso, Y., Akaza, H., Kotake, T., Tsukamoto, T., Imai, K. and Naito, S. (1995), Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. Eur. Urol. 27, 104-109.
12. Baricault, L., Denariaz, G., Houri, J-J., Bouley, C., Sapin, C. and Trugnan, G. (1995), Use of HT-29, a cultured human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation. Carcinogenesis 16, 245-252.
13. Bazzoli, E., Zagari, R.M., Fossi, S., Morelli, M.C., Pozzato, P., Novelli, G., Ventrucci, M., Mazzella, G., Festi, D. and Roda, E. (1992), In vitro Helicobacter pylori clearance failure with Lactobacillus acidophilus. Gastroenterology 102, A38.
14. Benno, Y. and Mitsuoka, T. (1992), Impact of Bifidobacterium longum on human fecal microflora. Microbiol. Immunol. 36, 683-694.
15. Bhatia, S.J., Kochar, N., Abraham, P., Nair, N.G. and Mehta, A.P. (1989), Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J. Clin. Microbiol. 27, 2328-2330.
16. Biasco, G., Paganelli, G.B., Brandi, G., Brillanti, S., Lami, F., Callegari, C. and Gizzi, G. (1991), Effect of Lactobacillus acidophilus and Bifidobacterium bifidum on rectal cell kinetics and fecal pH. Ital. J. Gastroenterol. 23, 142.
17. Biffi, A., Coradini, C., Larsen, R., Riva, L. and Di Fronzo, G. (1997), Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line. Nutr. Cancer 28, 93-99.
18. Bodana, A.R. and Rao, D.R. (1990), Anti-mutagenic activity of milk fermented by Streptococcus thermophilus and Lactobacillus bulgaricus. J. Dairy Sci. 73, 3379-3384.
19. Bolognani, F., Rumney, C.J. and Rowland, I.R. (1997), Influence of carcinogen binding by lactic-acid producing bacteria on tissue distribution and in vitro mutagenicity of dietary carcinogens. Food Chem. Toxicol. 35, 535-545.
20. Borriello, S.P., Drasar, B.S., Tomkins, A. and Hill, M. (1983), Relative carriage rates of nuclear dehydrogenating clostrida in two populations of different colorectal cancer risk. J. Clin. Pathol. 36, 93-95.
21. Bouhnik, Y., Flourie, B., Andrieux, C., Bisetti, N., Briet, F. and Rambaud, J-C. (1996a), Effects of Bifidobacterium spp fermented milk ingested with or without inulin on colonic bifidobacteria and enzymatic activities in healthy humans. Eur. J. Clin. Nutr. 50, 269-273.
22. Bouhnik, Y., Flourie, B., Riottot, M., Bisetti, N., Gailing, M-F., Guibert, A., Bornet, F. and Rambaud, J-C. (1996b), Effects of fructo-oligosaccharides ingestion on fecal bifidobacteria and selected metabolic indexes of colon carcinogenesis in healthy humans. Nutr. Cancer 26, 21-29.
23. Boutron, M-C., Faivre, J., Marteau, P., Couillault, C., Senesse, P. and Quipourt, V. (1996), Calcium, phosphorus, vitamin D, dairy products and colorectal carcinogenesis: a French case-control study. Br. J. Cancer 74, 145-151.
24. Boyd, N.F., Lockwood, G.A., Greenberg, C.V., Martin, L.J. and Tritchler, D.L. (1997), Effects of a low-fat high-carbohydrate diet on plasma sex hormones in premenopausal women: results from a randomized controlled trial. Br. J. Cancer 76, 127-135.
25. Buddington, R.K., Williams, C.H., Chen, S-C. and Witherly, S.A. (1996), Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. Am. J. Clin. Nutr. 63, 709-716.
26. Bueno de Mesquita, H.B., Maisonneuve, P., Runia, S. and Moerman, C.J. (1991), Intake of foods and nutrients and cancer of the exocrine pancreas: a population-based case-control study in The Netherlands. Int. J. Cancer 48, 540-549.
27. Campbell, R.L., Singh, D.V. and Nigro, N.D. (1975), Importance of the fecal stream on the induction of colon tumours by azoxymethane in rats. Cancer Res. 35, 1369-1371.
28. Cassand, P., Abdelali, H., Bouley, C., Denariaz, G. and Narbonne, J.F. (1994), Inhibitory effect of dairy products on the mutagenicities of chemicals and dietary mutagens. J. Dairy Res. 61, 545-552.
29. Challa, A., Rao, D.R., Chawan, C.B. and Shackelford, L. (1997), Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis 18, 517-521.
30. Chomchai, C., Bhadrachari, N. and Nigro, N.D. (1974), The effect of bile on the induction of experimental intestinal tumours in rats. Dis. Colon Rect. 17, 310-312.
31. Clinton, S.K., Bostwick, D.G., Olson, L.M., Mangian, H.J. and Visek, W.J. (1988), Effects of ammonium acetate and sodium chlorate on N-methyl-N-nitro-N-nitrosoguanidine-induced colon carcinogenesis of rats. Cancer Res. 48, 3035-3039.
32. Coconnier, M-H., Lievin, V., Hemery, E. and Servin, A.L. (1998), Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl. Environ. Microbiol. 64, 4573-4580.
33. Curren, R.D., Putman, D.L. Yang, L.L., Haworth, S.R., Lawlor, T.E., Plummer, S.M. and Harris, C.C. (1987), Genotoxicity of fecapentaene-12 in bacterial and mammalian cell assay systems. Carcinogenesis 8, 349-352.
34. Deeth, H.C. and Tamime, A.Y. (1981), Yogurt: nutritive and therapeutic aspects. J. Food Prot. 44, 78-86.
35. De Kok, T.M.C.M., Van Iersel, M.L.P.S., ten Hoor, F. and Kleinjans, J.C.S. (1993a), In vitro study on the effects of fecal composition on fecapentaene kinetics in the large bowel. Mutat. Res. 302, 103-108.
36. De Kok,. T.M.C.M., Van Faassen, A., Bausch-Goldbohm, R.A., ten Hoor, F. and Kleinjans, J.C.S. (1992), Fecapentaene excretion and fecal mutagenicity in relation to nutrient intake and fecal parameters in humans on omnivorous and vegetarian diets. Cancer Lett. 62, 11-21.
37. De Kok, T.M.C.M., Pachhen, D., Van Iersel, M.L.P.S., Baeten, C.G.M.I., Engels, L.G.J.B., ten Hoor, F. and Kleinjans, J.C.S. (1993b), Case-control study on fecapentaene excretion and adenomatous polyps in the colon and rectum. J. Natl Cancer Inst. 85, 1241-1244.
38. De Simone, C., Vesely, R., Bianchi Salvadori, B. and Jirillo, E. (1993), The role of probiotics in modulation of the immune system in man and in animals. Int. J. Immunotherapy IX, 23-28.
39. Doolittle, D.J., Rahn, C.A., Burger, G.T., Lee, C.K., Reed, B., Riccio, E., Howard, G., Passananti, G.T., Vesell, E.S. and Hayes, A.W. (1989), Effect of cooking methods on the mutagenicity of food and on urinary mutagenicity of human consumers. Food Chem. Toxic. 27, 657-666.
40. Drasar, B.S., Jenkins, D.J.A. and Cummings, J.H. (1976), The influence of a diet rich in wheat fibre on the human faecal flora. J. Med. Microbiol. 9, 423-431.
41. Duchmann, R., Kaiser, I., Hermann, E., Mayet, W., Ewe, K., and Myer Zum Buschenfelde, K-H. (1995), Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp. Immunol. 102, 448-455.
42. Falk, P.G., Hooper, L.V., Midtvedt, T. and Gordon, J.I. (1998), Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol. Mol. Biol. Rev. 62, 1157-1170.
43. Farkas-Himsley, H. (1980), Sensitivity to bacteriocins of murine leukaemias with varying oncogenic potency. Microbios Lett. 15, 89-96.
44. Feigelson, H.S. and Henderson, B. (1996), Estrogens and breast cancer. Carcinogenesis 17, 2279-2284.
45. Femandes, L. and Steele, J.L. (1993), Glutathione content of lactic acid bacteria. J. Dairy Sci. 76, 1233-1242.
46. Fichera, G.A. and Giese, G. (1994), Non-immunologically mediated cytotoxicity of Lactobacillus casei and its derivative peptidoglycan against tumour cell lines. Cancer Lett. 85, 93-103.
47. Finegold, S.M. and Sutter, V.L. (1978), Fecal flora in different populations, with special reference to diet. Am. J. Clin. Nutr. 31 S116-S122.
48. Friend, B.A. and Shahani, K.M. (1984), Antitumour properties of lactobacilli and dairy products fermented by lactobacilli. J. Food Prot. 47, 717-723.
49. Gallaher, D.D., Stallings, W.H., Blessing, L.L., Busta, F.F. and Brady, L.J. (1996), Probiotics, cecal microflora, and aberrant crypts in the rat colon. J. Nutr. 126, 1362-1371.
50. Gibson, G.R. and Roberfroid, M.B. (1995), Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 125, 1401-1412.
51. Gill, H.S. (1998), Stimulation of the immune system by lactic cultures. Int. Dairy J. 8, 535-544.
52. Goddard, P. and Hill, M.J. (1973), The dehydrogenation of the steroid nucleus by human-gut bacteria. Biochem. Soc. Trans. 1, 1113-1115.
53. Goldin, B.R. (1986), The metabolism of the intestinal microflora and its relationship to dietary fat, colon and breast cancer. Prog. Clin. Biol. Res. 222, 655-685.
54. Goldin, B.R. and Gorbach, S.L. (1976), The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer. J. Natl Cancer Inst. 57, 371-375.
55. Goldin, B.R. and Gorbach, S.L. (1977), Alterations in fecal microflora enzymes related to diet, age, lactobacillus supplements, and dimethylhydrazine. Cancer 40, 2421-2426.
56. Goldin, B.R. and Gorbach, S.L. (1981), Effects of antibiotics on incidence of rat intestinal tumours induced by 1,2-dimethylhydrazine dihydrochloride. J. Natl Cancer Inst. 67, 877-880.
57. Goldin, B.R. and Gorbach, S.L. (1984), Alterations to the intestinal microflora by diet, oral antibiotics, and Lactobacillus: decreased production of free amines from aromatic nitro compounds, azo dyes, and glucuronides. J. Natl Cancer Inst. 73, 689-695.
58. Goldin, B.R. and Gorbach, S.L. (1992), Probiotics for humans. In Probiotics, the Scientific Basis. (Ed R. Fuller). Chapman and Hall, London, pp 355-376.
59. Goldin, B.R. and Gorbach, S.L. (1994), Hormone studies and the diet and breast cancer connection. In Diet and Breast Cancer. (Ed American Institute for Cancer Research). Plenum Press, New York, pp 35-46.
60. Goldin, B.R., Gualtieri, L.J. and Moore, R.P. (1996), The effect of Lactobacillus GG on the initiation and promotion of DMH-induced intestinal tumours in the rat. Nutr. Cancer 25, 197-204.
61. Goldin, B.R., Dwyer, J., Gorbach, S.L., Gordon, W, and Swenson, L. (1978), Influence of diet and age on fecal bacterial enzymes. Am. J. Clin. Nutr. 31, S136-S140.
62. Goldin, B.R., Swenson, L., Dwyer, J., Sexton, M. and Gorbach, S.L. (1980), Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes. J. Natl Cancer Inst. 64, 255-261.
63. Goldin, B.R., Gorbach, S.L., Saxelin, M., Baraket, S., Gualtieri, L. and Salminen, S. (1992), Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig. Dis. Sci. 37, 121-128.
64. Gorbach, S.L. and Goldin, B.R. (1987), Diet and the excretion and enterohepatic cycling of estrogens. Preventive Med. 16, 525-531.
65. Guerin-Danan, C., Chabanet, C., Pedone, C., Popot, F., Viassade, P., Bouley, C., Szylit, O. and Andrieux, C. (1998), Milk fermented with yogurt cultures and Lactobacillus casei compared with yogurt and gelled milk: influence on intestinal microfiora in healthy infants. Am. J. Clin. Nutr. 67, 111-117.
66. Hamann, L., El-Samalouti, V., Ulmer, A.J., Fald, H-D. and Rietschel, E.T. (1998), Components of gut bacteria as immunomodulators. Int. J. Food Microbiol. 41, 141-154.
67. Hatcher, G.E. and Lambrecht, R.S. (1993), Augmentation of macrophage phagocytic activity by cell-free extracts of selected lactic acid-producing bacteria. J. Dairy Sci 76, 2485-2492.
68. Hayatsu, H. and Hayatsu, T. (1993), Suppressing effect of Lactobacillus casei administration on the urinary mutagenicity arising from ingestion of fried ground beef in the human. Cancer Lett. 73, 173-179.
69. Hennigan, T.W., Sian, M., Matthews, J. and Allen-Mersh, T.G. (1995), Protective role of lactulose in intestinal carcinogenesis. Surg. Oncol. 4, 31-34.
70. Hill, M.J. (1981), Diet and human intestinal bacterial flora. Cancer Res. 41, 3778-3780.
71. Hill, M.J. (1995), Bacterial fermentation of complex carbohydrate in the human colon. Eur. J. Cancer Prev. 4, 353-358.
72. Hill, M.J., Crowther, J.S., Drasar, B.S., Hawksworth, G., Aries, V. and Williams, R.E.O. (1971), Bacteria and aetiology of cancer of large bowel. Lancet I, 95-100.
73. Hill, M.J., Drasar, B.S., Williams, R.E.O., Meade, T.W., Cox, A.G., Simpson, J.E.P., and Morson. B.E. (1975), Faecal bile-acids and clostridia in patients with cancer of the large bowel. Lancet I, 535-539.
74. Hinzman, M.J., Novotny, C., Ullah, A. and Shamsuddin, A.M. (1987), Fecal mutagen fecapentaene-12 damages mammalian colon epithelial DNA. Carcinogenesis 8, 1475-1479.
75. Hosono, A., Kashina, T. and Kada, T. (1986), Antimutagenic properties of lactic acid-cultured milk on chemical and fecal mutagens. J. Dairy Sci. 69, 2237-2242.
76. Hosono, A., Wardojo, R. and Otani, H. (1990), Inhibitory effects of lactic acid bacteria from fermented milk on the mutagenicities of volatile nitrosamines. Agric. Biol. Chem. 54, 1639-1643.
77. Hosoda, M., Hashimoto, H., He, F., Monta, H. and Hosono, A. (1996), Effect of administration of milk fermented with Lactobacillus acidophilus LA-2 on fecal mutagenicity and microflora in the human intestine. J. Dairy Sci. 79, 745-749.
78. Hosoda, M., Hashimoto, H., Morita, H., Chiba, M. and Hosono, A. (1992a), Studies on antimutagenic effect of milk cultured with lactic acid bacteria on the Trp-P2-induced mutagenicity to TA98 strain of Salmonella typhimurium. J.Dairy Res. 59, 543-549.
79. Hosoda, M., Hashimoto, H., Moriti, H., Chiba, M. and Hosono, A. (1992b), Antimutagenicity of milk cultured with lactic acid bacteria against N-methyl-N-nitro-N-nitrosoguanidine. J. Dairy Sci. 75, 976-981.
80. Iannello, D., Bonina, L., Delfino, D., Berlinghieri, M.C. , Gismondo, M.R. and Mastroeni, P. (1984), Effect of oral administration of a variety of bacteria on depressed macrophage functions in tumour bearing rats. Ann. Immunol. (Inst. Pasteur) 135 C, 345-352.
81. Jarvenpaa. P., Kosunen, T. Adlercreutz, H. (1980), In vitro metabolism of estrogens by isolated intestinal micro-organisms and by human faecal microflora. J. Steroid Biochem. 13, 345-349.
82. Javitt, N.B., Budai, K., Miller, D.G., Cahan, C., Raju, U. and Levitz, M. (1994), Breast-gut connection: origin of chenodeoxycholic acid in breast cyst fluid. Lancet 343, 633-635.
83. Jenab, M., Rickard, S.E., Orcheson, L.J. and Thompson, L.U. (1999), Flax-seed and lignans increase cecal β-glucuronidase activity in rats. Nutr. Cancer 33, 154-158.
84. Johansson, G.K., Ottova, L. and Gustafsson, J-A. (1990), Shift from a mixed diet to a lactovegetarian diet: influence of some cancer associated intestinal bacterial enzyme activities. Nutr. Cancer 14, 239-246.
85. Johansson, G., Holmen, A., Persson, L., Hogstedt, B., Wassen, C., Ottova and Gustaffsson, J-A. (1997), Dietary influence on some proposed risk factors for colon cancer: Fecal and urinary mutagenic activity and the activity of some intestinal bacterial enzymes. Cancer Dect. Prev. 21, 258-266.
86. Kabir, A.M.A., Aiba, Y., Takagi, A., Kamiya, S., Miwa, T. and Koga, Y. (1997), Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 41, 49-55.
87. Kampman, E., Goldbohm, R.A., Van den Brandt, P.A. and Van't Veer, P. (1994a), Fermented dairy products, calcium, and colorectal cancer in the Netherlands cohort study. Cancer Res. 54, 3186-3190.
88. Kampman, E., Van't Veer, P., Hiddink, G.J., Van Aken-Schneijder, P., Kok, F.J. and Hermus, R.J.J. (1994b), Fermented dairy products, dietary calcium and colon cancer: a case-control study in the Netherlands. Int. J. Cancer 59, 170-176.
89. Kampman, E., Giovannucci, E., Van't Veer, P., Rimm, E., Stampfer, M.J., Colditz, G.A., Kok, F.J. and Willett, W.C. (1994c), Calcium, vitamin D, dairy foods, and the occurrence of colorectal adenomas among men and women in two prospective studies. Am. J. Epidemol. 139, 16-29.
90. Kanazawa, K., Konishi, F., Mitsuoka, T., Terada, A., Itoh, K., Narushima, S., Kumemura, M. and Kimura, H. (1996), Factors influencing the development of sigmoid colon cancer. Cancer 77, 1701-1706.
91. Kanbe, M. (1992), Cancer control and fermented milk. In Functions of Fermented Milk. (Eds Y. Nakazawa and A. Hosono). Elsevier Applied Science, London, pp 377-393.
92. Kato, I., Endo, K. and Yokokura, T. (1994), Effects of oral administration of Lactobacillus casei on antitumour responses induced by tumour resection in mice. Int. J. Immunopharmac. 16, 29-36.
93. Kearney, J., Giovannucci, E., Rimm, E.B. Ascherio, A., Stampfer, M.J., Colditz, G.A., Wing, A., Kampman, E. and Willett, W.E. (1996), Calcium, vitamin D, dairy foods and the occurrence of colon cancer in men. Am. J. Epidemiol. 143, 907-917.
94. Knekt, P., Jarvinen, R., Seppanen, R., Pukkala, E. and Aromaa, A. (1996), Intake of dairy products and the risk of breast cancer. Br. J. Cancer 73, 687-691.
95. Kot, E., Furmanov, S. and Bezkorovainy, A. (1995), Accumulation of iron in lactic acid bacteria and bifidobacteria. J. Food Sci. 60, 547-550.
96. Kripke, M.L. (1988), Immunoregulation of carcinogenesis: past, present, and future. J. Natl Cancer Inst. 80, 722-727.
97. Kulkarni, N. and Reddy, B.S. (1994), Inhibitory effect of Bifidobacterium longum cultures on the azoxymethane-induced aberrant crypt foci formation and fecal bacterial β-glucuronidase. Proc. Soc. Exp. Biol. Med. 207, 278-283.
98. Laqueur, G.I. (1970), Contribution of intestinal macroflora and microflora to carcinogenesis. In Carcinoma of the Colon and Antecedent Epithelium. (Ed W.J. Burdette).Charles C. Thomas Publishers, Springfield, Illinois, pp 305-313.
99. Le, M.G., Moulton, L.H., Hill, C. and Kramar, A. (1986), Consumption of dairy produce and alcohol in a case-control study of breast cancer. J. Natl Cancer Inst. 77, 633-636.
100. Lee, H., Rangavajhyala, N., Grandjean, C. and Shahani, K.M. (1995), Inhibitory effects of Lactobacillus acidophilus on transformation of bile acids by human fecal microflora. Microbiol. Aliments Nutr. 13, 241-247.
101. Lee, H., Rangavajhyala, N., Grandjean, C. and Shahani, K.M. (1996), Anticarcinogenic effects of Lactobacillus acidophilus on N-nitrosobis(2-oxopropyl)amine induced colon tumour in rats. J. Appl. Nutr. 48, 59-66.
102. Lee, Y-K. and Salminen, S. (1995), The coming of age of probiotics. Trends Food Sci. Technol. 6, 241-245.
103. Lewin, M.R., Ferulano, G.P. Cruse, J.P. and Clark, C.G. (1981), Experimental colon carcinogenesis is facilitated by endogenous factors in the intestinal contents. Carcinogenesis 12, 1363-1366.
104. Lidbeck, A., Nord, C.E., Gustafsson, J-A, and Rafter, J. (1992a), Lactobacilli, anticarcinogenic activities and human intestinal microflora. Eur. J. Cancer Prev. 1, 341-353.
105. Lidbeck, A., Overvik, E., Rafter, J., Nord, C.E. and Gustafsson. J-A. (1992b), Effect of Lactobacillus acidophilus supplements on mutagen excretion in faeces and urine in humans. Microb. Ecol. Hlth Dis. 5, 59-67.
106. Lidbeck, A., Allinger, U.G., Orrhage, K.M., Ottova, L., Brismar, B., Gustafsson, J-A., Rafter, J.J. and Nord, C.E. (1991), Impact of Lactobacillus acidophilus supplements on the faecal microflora and soluble faecal bile acids in colon cancer patients. Microb. Ecol. Hlth Dis. 4, 81-88.
107. Lindop, R., Tasman-Jones, C., Thomsen, L.L. and Lee, S.P. (1985), Cellulose and pectin alter intestinal β glucuronidase (EC 3.2.1.31) in the rat. Br. J. Nutr. 54, 21-26.
108. Ling, W.H. and Hanninen, O. (1992), Shifting from a conventional diet to an uncooked vegan diet reversibly alters fecal hydrolytic activities in humans. J. Nutr. 122, 924-930.
109. Ling, W.H., Korpela, R., Mykkanen, H., Salminen, S. and Hanninen. O. (1994), Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J. Nutr. 124, 18-23.
110. Macdonald, I.A., Singh, G., Mahony, D.E. and Meier, C.E. (1978), Effect of pH on bile salt degradation by mixed fecal cultures. Steroids 32, 245-256.
111. Malhotra, S.L. (1977), Dietary factors in a study of cancer colon from cancer registry, with special reference to the role of saliva, milk and fermented milk products and vegetable fibre. Med. Hypoth. 3, 122-126.
112. Mallett, A.K., Rowland, I.R. and Wise, A. (1984), Dietary fat and cecal microbial activity in the rat. Nutr. Cancer 6, 86-91.
113. Mallett, A.K, Rowland, I.R., Bearne, C.A., Flynn, J.C., Fehilly, B.J., Udeen, S. and Farthing, M.J.G. (1988), Effect of dietary supplements of apple pectin, wheat bran or fat on the enzyme activity of the human faecal flora. Microb. Ecol. Hlth Dis. 1, 23-29.
114. Marin, M.L., Lee, J.H., Murtha, J., Ustunol, Z. and Pestka, J.J. (1997), Differential cytokine production in clonal macrophage and T-cell lines cultured with bifidobacteria. J. Dairy Sci. 80, 2713-2720.
115. Mastromarino, A.J., Reddy, B.S. and Wynder, E.L. (1978), Fecal profiles of anaerobic microflora of large bowel cancer patients and patients with nonhereditary large bowel polyps. Cancer Res. 38, 4458-4462.
116. Matar, C., Nadathur, S.S., Bakalinsky, A.T. and Goulet, J. (1997), Anti-mutagenic effects of milk fermented by Lactobacillus helveticus L89 and a protease-deficient derivative. J. Dairy Sci. 80, 1965-1970.
117. Matsuzaki, T. (1998), Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int. J. Food Microbiol. 41, 133-140.
118. Matsuzaki, T. and Yokokura, T. (1989), Antitumour effect of oral administration of Lactobacillus casei in newborn mice. Igaku no Ayumi 150, 745-746.
119. McCann, J., Choi, E., Yamasaki, E. and Ames, B.N. (1975), Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc. Natl Acad. Sci.USA 72, 5135-5139.
120. McCarthy, A.C., La, E., Conti, C.J. and Locniskar, M.F. (1997), Effect of spray-dried yogurt and lactic acid bacteria on the initiation and promotion stages of chemically induced skin carcinogenesis in mice. Nutr. Cancer 27, 231-237.
121. McFarlane, G.A. and Munro, A. (1997), Helicobacter pylori and gastric cancer. Br. J. Surg. 84, 1190-1199,
122. McGroarty, J.A., Hawthorn, L-A, and Reid, G. (1988), Anti-tumour activity of lactobacilli in vitro. Microbios Lett. 39, 105-112.
123. McIntyre, A., Gibson, P.R. and Young, G.P. (1993), Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 34, 386-391.
124. Michetti, P., Dorta, G., Brassard, D., Vouillamoz, D., Schwitzer, W., Felley, C., Blum, A.L., Porta, N., Rouvet, W. and Corthesy-Theulaz, I. (1995), L. acidophilus supernatant as an adjuvant in the therapy of H. pylori in humans. Gastroenterology 108, A166.
125. Midolo, P.D., Lambert, J.R., Hull, R., Luo, F, and Grayson, M.L. (1995), In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J. Appl. Bact. 79, 475-479.
126. Mishra, C., Lambert, J. and Midolo, P. (1996), Anti-Helicobacter pylori effect of yogurt. J. Gastroenterol. Hepatol. 11 (Suppl.1) A34.
127. Moore, W.E.C. and Moore, L.H. (1995), Intestinal floras of populations that have a high risk of colon cancer. Appl. Environ. Microbiol. 61, 3202-3207.
128. Morotomi, M. and Mutai, M. (1986), In vitro binding of potent mutagenic pyrolyzates of intestinal bacteria. J. Natl Cancer Inst. 77, 195-201.
129. Morotomi, M., Guillem, J.C., LoGerfo, P. and Weinstein, I.B. (1990), Production of diacylglycerol, an activator of protein kinase C, by human intestinal microflora. Cancer Res. 50, 3595-3599.
130. Nadathur, S.R., Gould, S.J. and Bakalinsky, A.T. (1994), Antimutagenicity of fermented milk. J. Dairy Sci. 77, 3287-3295.
131. Nagengast, F.M., Grubben, M.J.A.L. and Van Munster, I.P. (1995), Role of bile acids in colorectal carcinogenesis. Eur. J. Cancer 31A, 1067-1070.
132. Nagengast, F.M., Hectors, M.P.C., Buys, W.A.M. and Van Tongeren, J.H.M. (1988), Inhibition of secondary bile acid formation in the large intestine by lactulose in healthy subjects of two different age groups. Eur. J. Clin. Invest. 18, 56-61.
133. Newmark, H.L. and Lupton, J.R. (1990), Determinants and consequences of colonic luminal pH: implications for colon cancer. Nutr. Cancer 14, 161-173.
134. Nigro, N.D., Bhadrachari, N. and Chomchai, C. (1973), A rat model for studying colon cancer. Dis. Colon Rect. 16, 438-443.
135. Nobre-Leitao, C., Lage, P., Cravo, M., Cabecadas, J., Chaves, P., Alberto-Santos, A., Correia, J., Scares, J.and Costa-Mira, F. (1997), Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: a study controlled by endoscopie ultrasonography. Am. J. Gastroenterol. 93, 732-736.
136. Oda, T., Seto, Y. and Hashiba, H. (1998), Supplementation of Bifidobacterium longum to a high-fat, low-calcium diet lowers cytolytic activity of fecal water in rats injected with 1,2-dimethylhydrazine dihydrochloride. J. Nutr. Sci. Vitaminol. 44, 187-194.
137. Ohkusa, T., Takashimizu, I., Fujiki, K., Suzuki, S., Shimoi, K., Horiuchi, T., Sakurazawa, T., Ariake, K., Ishii, K., Kumagi, J. and Tanizawa, T. (1998), Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. Ann. Intern. Med. 129, 712-715.
138. Orrhage, K., Sillerstrom, E., Gustafsson, J-A., Nord, C.E. and Rafter, J. (1994), Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria. Mutat. Res. 311, 239-248.
139. Overvik, E. and Gustafsson, J-A. (1990), Cooked-food mutagens: current knowledge of formation and biological significance. Mutagenesis 5, 437-446.
140. Overvik, E., Lindeskog, P., Midtvedt, T. and Gustafsson, J-A. (1990), Mutagen excretion and cytochrome P-450-dependent activity in germfree and conventional rats fed a diet containing fried meat. Fd Chem. Toxic. 28, 253-261.
141. Parodi, P.W. (1997), Cow's milk folate binding protein: its role in folate nutrition. Aust. J. Dairy Technol. 52, 109-118.
142. Parodi, P.W. (1998), A role for milk proteins in cancer prevention. Aust. J. Dairy Technol. 53, 37-47.
143. Parodi, P.W. (1999), Conjugated linoleic acid and other anticarcinogenic agents of bovine milk fat. J. Dairy Sci. 82, 1339-1349.
144. Parsonnet, J. (1995), Bacterial infection as a cause of cancer. Environ. Health Perspect. 103 (Suppl.8), 263-268.
145. Pedrosa, M.C., Golner, B.B., Goldin, B.R., Barakat, S., Dallal, G.E. and Russell, R.M. (1995), Survival of yogurt-containing organisms and Lactobacillus gasseri (ADH) and their effect on bacterial enzyme activity in the gastrointestinal tract of healthy and hypochlorhydric elderly subjects. Am. J. Clin. Nutr. 61, 353-358.
146. Penn, I. (1988), Tumours of the immunocompromised patient. Ann. Rev. Med. 39, 63-73.
147. Perdigon, G. and Alvarez, S. (1992), Probiotics and the immune state. In Probiotics: The Scientific Basis. (Ed R. Fuller). Chapman and Hall, London, pp 145-180.
148. Perdigon, G., Valdez, J.C. and Rachid, M. (1998), Antitumour activity of yogurt: study of possible immune mechanisms. J. Dairy Res. 65,129-138.
149. Perdigon, G., Alvarez, S., Rachid, M., Aguero, G. and Gobbato, N. (1995), Probiotic bacteria for humans: clinical systems for evaluation of effectiveness. J. Dairy Sci. 78, 1597-1606.
150. Peters R.K., Pike, M.C., Garabrant, D. Mack, T.M. (1992), Diet and colon cancer in Los Angeles County, California. Cancer Causes Control 3, 457-473.
151. Pierre, F., Perrin, P., Champ, M., Bornet, F., Meflah, K. and Menanteau, J. (1997), Short-chain fructo-oligosaccharides reduce the occurrence of colon tumors and develop gut-associated lymphoid tissue in Min mice. Cancer Res. 57, 225-228.
152. Pool-Zobel, B.L., Neudecker, C., Domizlaff, I., Ji, S., Schillinger, U., Rumney, C., Moretti, M., Vilarini, I., Scassellati-Sforzolini, R. and Rowland, I. (1996), Lactobacillus- and Bifidobacterium-mediated antigenotoxicity in the colon of rats. Nutr. Cancer 26, 365-380.
153. Pozharisskii, K.M., Dushkin, V.A. and Podoprigora, G.I. (1974), The role of microbial flora in the induction of intestinal tumours in rats. Byull. Eksp. Biol. Med. 78, 81-84.
154. Prehn, R.T. (1994), Stimulatory effects of immune reactions upon the growths of untransplanted tumours. Cancer Res. 54, 908-914.
155. Rafter, J.J. (1995), The role of lactic acid bacteria in colon cancer prevention. Scand. J. Gastroenterol. 30, 497-502.
156. Reddy, B S. (1990), Intestinal microflora and carcinogenesis. Bifidobacteria Microflora 9, 65-76.
157. Reddy, B.S. and Ohmori, T. (1981), Effect of intestinal microflora and dietary fat on 3,2¢-dimethyl-4-aminobiphenyl-induced colon carcinogenesis in F344 rats. Cancer Res. 41, 1363-1367.
158. Reddy, B.S. and Rivenson, A. (1993), Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Cancer Res. 53, 3914-3918.
159. Reddy, B.S. and Watanabe, K. (1978), Effect of intestinal microflora on 3,2¢-dimethyl-4-aminobiphenyl-induced carcinogenesis in F344 rats. J. Natl Cancer Inst. 61, 1269-1271.
160. Reddy, B.S. and Wynder, E.L. (1973), Large-bowel carcinogenesis: Fecal constituents of populations with diverse incidence rates of colon cancer. J. Natl Cancer Inst. 50, 1437-1442.
161. Reddy, B.S., Hamid, R. and Rao, C.V. (1997), Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis 18, 1371-1374.
162. Reddy, B.S., Narisawa, T. and Weisburger, J.H. (1976), Colon carcinogenesis in germ-free rats with intrarectal 1,2-dimethylhydrazine and subcutaneous azoxymethane. Cancer Res. 36, 2874-2876.
163. Reddy, B.S., Pleasants, J.R. and Wostmann, B.S. (1973), Metabolic enzymes in liver and kidney of the germfree rat. Biochim. Biophys. Acta 320, 1-8.
164. Reddy, B.S., Weisburger, J.H. and Wynder, E.L. (1974a), Fecal bacterial b-glucuronidase: control by diet. Science 183, 416-417.
165. Reddy, B.S., Hedges, A.R., Laakso, K. and Wynder, E.L. (1978), Metabolic epidemiology of large bowel cancer. Cancer 42, 2832-2838.
166. Reddy, B.S., Mangat, S., Weisburger, J.H. and Wynder, E.L. (1977), Effect of high-risk diets for colon carcinogenesis on intestinal mucosal and bacterial b-glucuronidase activity in F344 rats. Cancer Res. 37, 3533-3536.
167. Reddy, B.S., Weisburger, J.H., Narisawa, T. and Wynder, E.L. (1974b), Colon carcinogenesis in germ-free rats with 1,2-dimethylhydrazine and N-methyl-N¢-nitro-N-nitrosoguanidine. Cancer Res. 34, 2368-2372.
168. Reddy, B.S., Simi, B., Patel, N., Aliaga, C. and Rao, C.V. (1996), Effect of amount and types of dietary fat on intestinal 7a-dehydroxylase and phosphatidylinositol-specific phospholipase C and colonic mucosal diacylglycerol kinase and PKC activities during different stages of colon tumor promotion. Cancer Res. 56, 2314-2320.
169. Reddy, B.S., Narisawa, T., Wright, P., Vukusich, D., Weisburger, J.H. and Wynder, E.L. (1975), Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ free rats. Cancer Res. 35, 287-290.
170. Reddy B.S., Hanson, D., Mangat, S., Mathews, L., Sbaschnig, M., Sharma, C. and Simi, B. (1980), Effect of high-fat, high-beef diet and of mode of cooking of beef in the diet on fecal bacterial enzymes and bile acids and neutral sterols. J. Nutr. 110, 1880-1887.
171. Renner, H.W. and Munzner, R. (1991), The possible role of probiotics as dietary antimutagens. Mutat. Res. 262, 239-245.
172. Report from the International Agency for Research on Cancer Intestinal Microecology Group. (1977), Dietary fibre, transit-time, faecal bacteria, steroids, and colon cancer in two Scandinavian populations. Lancet ii, 207-211.
173. Rice, L.J., Chai, Y-J., Conti, C.J., Willis, R.A. and Locniskar, M.F. (1995), The effect of dietary fermented milk products and lactic acid bacteria on the initiation and promotion stages of mammary carcinogenesis. Nutr. Cancer 24, 99-109.
174. Ross, J.K. and Leklem, J.E. (1981), The effect of dietary citrus pectin on the excretion of human fecal neutral and acid steroids and the activity of 7a-dehydroxylase and b-glucuronidase. Am. J. Clin. Nutr. 34, 2068-2077.
175. Rowland, I.R. (1992), Metabolic interactions in the gut. In Probiotics: The Scientific Basis. (Ed R. Fuller). Chapman and Hall, London, pp 29-53.
176. Rowland, I.R. and Grasso, P. (1975), Degradation of N-nitrosamines by intestinal bacteria. Appl. Microbiol. 29, 7-12.
177. Rowland, I.R. and Tanaka, R. (1993), The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with a human faecal microflora. J. Appl. Bacteriol. 74, 667-674.
178. Rowland, I.R. , Mallett, A.K. and Wise, A. (1985), The effect of diet on the mammalian gut flora and its metabolic activities. CRC Crit. Rev. Toxicol. 16, 31-103.
179. Rowland, I.R., Rumney, C.J., Coutts, J.T. and Lievense, L.C. (1998), Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 19, 281-285.
180. Rubio, C.A., Nylander, G. and Santos, M. (1980), Experimental colon cancer in the absence of intestinal contents in Sprague-Dawley rats. J. Natl Cancer Inst. 64, 569-572.
181. Rumney, C.J., Rowland, I.R., Coutts, T.M., Randerath, K., Reddy, R., Shah, A.B., Ellul, A. and O'Neill, I.K.O. (1993), Effects of risk-associated human dietary macrocomponents on processes related to carcinogenesis in human-flora-associated (HFA) rats. Carcinogenesis 14, 79-84.
182. Salvioli, G., Salati, R., Bondi, M., Fratalocchi, A., Sala, B.M. and Gibertini, A. (1982), Bile acid transformation by the intestinal flora and cholesterol saturation in bile. Digestion 23, 80-88.
183. Salyers, A.A., Palmer, J.K. and Wilkins, T.D. (1977), Laminarinase (β-glucanase) activity in Bacteroides from the human colon. Appl. Environ. Microbiol. 33, 1118-1124.
184. Sanders, M.E. (1993), Effect of consumption of lactic cultures on human health. Adv. Food Nutr. Res. 37, 67-130.
185. Savage, D.C. (1977), Microbial ecology of the gastrointestinal tract. Ann. Rev. Microbiol. 31, 107-133.
186. Sawamura, A., Yamaguchi, Y., Toge, T., Nagata, N., Ikeda, H., Nakanishi, K. and Asakura, A. (1994), Enhancement of immuno-activities by oral administration of Lactobacillus casei in colorectal cancer patients. Biotherapy 8, 1567-1572.
187. Schiffman, M.H., Van Tassell, R.L., Robinson, A.R., Smith, L., Daniel, J., Hoover, R.N., Weil, R., Rosenthal, J., Nair, P.P., Schwartz, S., Pettigrew, H., Curiale, S., Batist, G., Block, G. and Wilkins, T.D. (1989), Case-control study of colorectal cancer and fecapentaene excretion. Cancer Res. 49, 1322-1326.
188. Sekine, K., Ushida, Y., Kuhara, T., Iigo, M., Baba-Toriyama, H., Moore, M.A., Murakoshi, M., Satomi, Y., Nishino, H., Kakizoe, T. and Tsuda, H. (1997), Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane. Cancer Lett. 121, 211-216.
189. Shamsuddin, A.M., Ullah, A., Baten, A. and Hale, E. (1991), Stability of fecapentaene-12 and its carcinogenicity in F-344 rats. Carcinogenesis 12, 601-607.
190. Simon, G.L. and Gorbach, S.L. (1984), Intestinal flora in health and disease. Gastroenterology 86, 174-193.
191. Singh, J., Rivenson, A., Tomita, M., Shimamura, S., Ishibashi, N. and Reddy, B.S. (1997), Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 18, 833-841.
192. Slattery, M.L., Potter, J.D. and Sorenson, A.W. (1994), Age and risk factors for colon cancer (United States and Australia): are there implications for understanding differences in case-control and cohort studies? Cancer Causes Control 5, 557-563.
193. Solis-Pereyra, B., Aattouri, N. and Lemonnier, D. (1997), Role of food in the stimulation of cytokine production. Am. J. Clin. Nutr. 66, 521S-525S.
194. Sotomayor, E.M., Borrello, I. and Levitsky, H.I. (1996), Tolerance and cancer: a critical issue in tumour immunology. Crit. Rev. Oncog. 7, 433-456.
195. Spanhaak, S., Havenaar, R. and Schaafsma, G. (1998), The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur. J. Clin. Nutr. 52, 899-907.
196. Sreekumar, O. and Hosono, A. (1998), Antimutagenicity and the influence of physical factors in binding Lactobacillus gasseri and Bifidobacterium longum cells to amino acid pyrolysates. J. Dairy Sci. 81, 1508-1516.
197. Stephen, A.M. and Cummings, J.H. (1980), The microbial contribution to human faecal mass. J. Med. Microbiol. 13, 45-56.
198. Takada, H., Hirooka, T., Hiramatsu, Y. and Yamamoto, M. (1982), Effect of β-glucuronidase inhibitor on azoxymethane-induced colonic carcinogenesis in rats. Cancer Res. 42, 331-334.
199. Takahashi, T and Morotomi, M. (1994), Absence of cholic acid 7α-dehydroxylase activity in the strains of Lactobacillus and Bifidobacterium. J. Dairy Sci. 77, 3275-3286.
200. Terada, A., Hara, H., Kataoka, M. and Mitsuoka, T. (1992), Effect of lactulose on the composition and metabolic activity of the human faecal flora. Microbiol. Ecol. Hlth Dis. 5, 43-50.
201. Tlaskalova-Hogenova, H., Sterzl, J., Stepankova, R., Dlabac, V., Vetvicka, V., Rossmann, P., Mandel, L. and Rejnek, J. (1983), Development of immunological capacity under germfree and conventional conditions. Ann. N. Y. Acad. Sci. 409, 96-113.
202. Tomita, K., Akaza, H., Nomoto, K., Yokokura, T. Matsushima, H. Homma, Y. and Aso, Y. (1994), Influence of Lactobacillus casei on rat bladder carcinogenesis. Nihon Hinyoukika Gakkaishi 85, 655-663.
203. Valdez, J.C., Rachid, M., Bru, E. and Perdigon, G. (1997), The effect of yogurt on the cytotoxic and phagocytic activity of macrophages in tumorbearing mice. Food Agric. Immunol. 9, 299-308.
204. Van Berge Henegouwen, G.P., Van der Werf, S.D.J. and Ruben, A.T. (1987), Effect of long term lactulose ingestion on secondary bile salt metabolism in man: potential protective effect of lactulose in colonic carcinogenesis. Gut 28, 675-680.
205. Van Boekel, M.A.J.S., Goeptar, A.R. and Alink, G.M. (1997). Antimutagenic activity of casein against MNNG in the E. coli DNA repair host-mediated assay. Cancer Lett. 114, 85-87.
206. Van Munster, I.P., Tangerman, A., De Hann, A.F.J. and Nagengast, F.M.(1993), A new method for the determination of the cytotoxicity of bile acids and aqueous phase of stool: the effect of calcium. Eur. J. Clin. Invest. 23, 773-777.
207. Van Tassell, R.L. Kingston, D.G.I, and Wilkins, T.D. (1990), Metabolism of dietary genotoxins by the human colonic microflora; the fecapentaenes and heterocyclic amines. Mutat. Res. 238, 209-221.
208. Van't Veer, P., van Leer, E.M., Rietdijk, A., Kok, F.J., Schouten, E.G., Hermus, R.J.J. and Sturmans, F. (1991), Combination of dietary factors in relation to breast-cancer occurrence. Int. J. Cancer 47, 649-653.
209. Van't Veer, P., Dekker, J.M., Lamers, J.W.J., Kok, F.J., Schouten, E.G., Brants, H.A.M., Sturmans, F. and R.J.J. Hermus. (1989), Consumption of fermented milk products and breast cancer: a case control study in the Netherlands. Cancer Res. 49, 4020-4023.
210. Watanabe, T., Tada, M., Nagai, H., Sasaki, S, and Nakao, M. (1998), Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 115, 642-648.
211. Weisburger, E.K. (1994), General principles of chemical carcinogenesis. In Carcinogenesis (Eds M.P. Waalkes and J.M. Ward). Raven Press, New York, pp 1-23.
212. Weisburger, J.H. (1971), Colon carcinogens: their metabolism and mode of action. Cancer 28, 60-70.
213. Weisburger, J.H., Reddy, B.S. and Wynder, E.L. (1977), Colon cancer: its epidemiology and experimental production. Cancer 40, 2414-2420.
214. Wheeler, J.G., Bogle, M.L., Shema, S.J., Shirell, M.A. Stine, K.C., Pittler, A.J., Burks, A.W. and Helm, R.M. (1997), Impact of dietary yogurt on immune function. Am. J. Med. Sci. 313, 120-123.
215. Williamson, R.C.N., Bauer, F.L.R., Ross, J.S., Watkins, J.B. and Malt, R.A. (1979), Enhanced colonic carcinogenesis with azoxymethane in rats after pancreaticobiliary diversion to mid small bowel. Gastroenterology 76, 1386-1392.
216. Wise, A., Mallett, A.K. and Rowland, I.R. (1983), Dietary protein and cecal microbial metabolism in the rat. Nutr. Cancer 4, 267-272.
217. Wollowski, I., Ji, S-T., Bakalinsky, A.T., Neudecker, C. and Pool-Zobel, B.L. (1999), Bacteria used for the production of yogurt inactivate carcinogens and prevent DNA damage in the colon of rats. J. Nutr. 129, 77-82.
218. Woods, M.N., Barnett, J.B., Spiegelman, D., Trail, N., Hertzmark, E., Longcope, C. and Gorbach, S.L. (1996), Hormone levels during dietary changes in premenopausal African-American women. J. Natl Cancer Inst. 88, 1369-1374.
219. Young, M.R.I. (1994), Eicosanoids and the immunology of cancer. Cancer Metastasis Rev. 13, 337-348.
220. Young, T.B. and Wolf, D.A. (1988), Case-control study of proximal and distal colon cancer and diet in Wisconsin. Int. J. Cancer. 42, 167-175.
221. Zhang, X.B. and Ohta, Y. (1991), Binding of mutagens by fractions of the cell wall skeleton of lactic acid bacteria on mutagens. J. Dairy Sci. 74, 1477-1481.
222. Zhang, X.B. and Ohta, Y. (1993), Microorganisms in the gastrointestinal tract of the rat prevent absorption of the mutagen-carcinogen 3-amino-1,4-dimethyl-5H-pyrido(4,3-6)indole. Can. J. Microbiol. 39, 841-845.
223. Zarkovic, M., Qin, X., Nakatsura, Y., Oda, H., Nakamura, T., Shamsuddin, A.M. and Ishikawa, T. (1993), Tumour promotion by fecapentaene-12 in a rat colon carcinogenesis model. Carcinogenesis 14, 1261-1264.